“…That review pointed out that sulfated cyclodextrins [2], including the single-isomer, regioselectively substituted 6-O-sulfo CDs [3][4][5][6][7][8][9][10] were the most widely used resolving agents for the separation of the enantiomers of pharmaceuticals. The objective of this paper is to describe the large-scale synthesis, analytical characterization and initial CE screening results for the third member of the single-isomer, sulfated a-CD family, the sodium salt of hexakis(2,3-di-O-methyl-6-O-sulfo)-a-CD (HxDMS) that completes the array of single-isomer, 6-O-sulfo CDs now available, namely the three b-CD derivatives (heptakis(6-Osulfo)-b-CD, HS [4], heptakis(2,3-di-O-acetyl-6-O-sulfo)-b-CD, HDAS [3], and heptakis(2,3-di-O-methyl-6-Osulfo)-b-CD, HDMS [5]), the three g-CD derivatives (octakis(6-O-sulfo)-g-CD, OS [7], octakis(2,3-di-O-acetyl-6-Osulfo)-g-CD, ODAS [6], and octakis(2,3-di-O-methyl-6-Osulfo)-g-CD, ODMS [8]), and the two a-CD derivatives (hexakis(6-O-sulfo)-a-CD, HxS [10], and hexakis(2,3-di-O-acetyl-6-O-sulfo)-a-CD, HxDAS [9]).…”